It is evident from Table 2 that multiple studies included in the literature have investigated the impact of high expression of lncRNA HOXA-AS2, CRNDE, ZEB2-AS1, TUG1, and MALAT-1 on the prognosis of AML patients. This evidence concerns the gene CRNDE and acute myeloid leukemia.